| Financial Year |
March 31 2023 |
| Monetary Funds |
153,872,255.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
36,845,587.33 |
| Advances to Suppliers |
177,478,167.38 |
| Other Receivables |
2,241,504.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
402,477,553.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,765,335.76 |
| Total Current Assets |
879,527,970.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
570,369,771.96 |
| Investment Properties |
-- |
| Fixed Assetes |
2,711,543,098.10 |
| Under-construction Projects |
47,523,443.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
151,223,746.01 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
24,979,810.47 |
| Sub-Total of Non-Current Assets |
4,346,637,896.70 |
| Total Assets |
5,226,165,867.17 |
| Short-Term Loans |
258,330,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,450,000.00 |
| Accounts Payable |
516,374,487.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
200,945,451.60 |
| Taxes Payable |
41,950,652.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
78,780,667.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
605,516,388.64 |
| Other Current Liabilities |
31,823,762.07 |
| Sub-Total of Current Liabilities |
2,005,063,746.13 |
| Long-term Loans |
80,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
186,094,374.44 |
| Deferred Income Tax Liabilities |
66,130,280.08 |
| Other Non-Current Liabilities |
17,181,190.37 |
| Sub-Total of Non-Current Liabilities |
814,102,379.77 |
| Total Liabilities |
2,819,166,125.90 |
| Paid-In Capital(Or Share Stock) |
1,006,800,000.00 |
| Capital Surplus |
1,705,236,634.35 |
| Surplus Reserve |
132,478,102.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-445,901,940.56 |
| Minority Stockholder's Interest |
8,727,579.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,398,272,161.58 |
| Owner's Equity（Stockholder's Equity） |
2,406,999,741.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,226,165,867.17 |
